Furthermore, aromatase gene polymorphisms may affect the risk of AD in humans, particularly in women (Iivonen et al., 2004; Huang and Poduslo, 2006; Janicki et al., 2013; Medway et al., 2014). Here, CYP19A1 is linked to Alzheimer disease.